It would appear that some irrational investors piled into UPS immediately following its February 1, 2022 announcement of record results, strong FY2022 guidance, and a
Category: Dividend Contenders
In my last article for Dividend Power, I discussed how the omicron variant and the fear of lockdowns lowered the market to over 4%. However,
There are many high-quality dividend stocks in the financial sector. For example, approximately 11% of the Dividend Aristocrats list comes from the financial sector. This article will highlight
Pharma stocks performed relatively poorly in 2021. The SPDR S&P Pharmaceuticals ETF (XPH) was down about (-10.5%), and the SPDR S&P Biotech ETF (XBI) was
This post looks at whether Merck stock is a good buy following a transformational divestiture and acquisition in 2021. In my February 8, 2021 Merck
We looked at the best performing dividend growth stocks in 2021. This list differs from the best performing stocks since it requires a company to
As 2022 starts, I like to look ahead and think about my top 3 dividend growth stock picks for the New Year. This year I
Is Visa a Good Stock to Buy? Some investors limit their knowledge of a company to its stock price behaviour. This, however, is a fundamentally
Spire (SR) is one of the oldest continuously operating independent natural gas utilities in the US. The stock price has been pressured since April 2021
Northrop Grumman (NOC) is one of the most prominent US aerospace and defense contractors based on revenue. The stock is rarely undervalued. However, as a